Brighton Jones LLC Crispr Therapeutics Ag Transaction History

Brighton Jones LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$38.62 - $72.18 $133,239 - $249,021	3,450 New	3,450 $215,000
Q2 2023 Jul 31, 2023	BUY	$43.47 - $67.77 $165,186 - $257,525	3,800 New	3,800 $213,000
Q3 2022 Nov 09, 2022	SELL	$61.1 - $83.78 $3,727 - $5,110	-61 Reduced 1.57%	3,830 $250,000
Q2 2022 Aug 04, 2022	BUY	$43.23 - $73.83 $4,495 - $7,678	104 Added 2.75%	3,891 $236,000
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $4,521 - $6,735	85 Added 2.3%	3,787 $238,000
Q4 2021 Feb 03, 2022	BUY	$70.09 - $111.29 $54,459 - $86,472	777 Added 26.56%	3,702 $281,000
Q3 2021 Nov 04, 2021	BUY	$110.2 - $156.64 $49,700 - $70,644	451 Added 18.23%	2,925 $327,000
Q2 2021 Aug 10, 2021	BUY	$100.84 - $161.89 $705 - $1,133	7 Added 0.28%	2,474 $401,000
Q1 2021 May 07, 2021	SELL	$110.72 - $210.04 $6,089 - $11,552	-55 Reduced 2.18%	2,467 $301,000
Q4 2020 Feb 10, 2021	BUY	$79.67 - $173.23 $1,274 - $2,771	16 Added 0.64%	2,522 $386,000
Q3 2020 Nov 12, 2020	BUY	$78.5 - $100.64 $196,721 - $252,203	2,506 New	2,506 $210,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.